Literature DB >> 12527539

Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction.

George S Alexopoulos1, Patrick Raue, Patricia Areán.   

Abstract

OBJECTIVE: The authors compared the efficacy of problem-solving therapy (PST) and supportive therapy (ST) in a group of elderly subjects with impairment in executive functions. This group was targeted because it has been shown to be at the risk for poor response to pharmacotherapy.
METHODS: A total of 25 elderly subjects with major depression and abnormal scores in initiation/perseveration and response inhibition tasks were randomly assigned to receive weekly sessions of PST or ST for 12 weeks. The subjects were systematically evaluated by raters blind to the study hypotheses.
RESULTS: PST was more effective than ST in leading to remission of depression, fewer post-treatment depressive symptoms, and less disability. A substantial part of the change in depression and disability was explained by the subjects' improvement of skills in generating alternatives and in decision-making.
CONCLUSION: This preliminary study suggests that PST is effective in reducing depressive symptoms and disability in elderly patients with major depression and executive dysfunction. If these findings are confirmed, PST may become an important therapeutic alternative for a patient population who may otherwise remain symptomatic and disabled.

Entities:  

Mesh:

Year:  2003        PMID: 12527539

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  63 in total

1.  Association of attentional shift and reversal learning to functional deficits in geriatric depression.

Authors:  Guy G Potter; Douglas R McQuoid; Martha E Payne; Warren D Taylor; David C Steffens
Journal:  Int J Geriatr Psychiatry       Date:  2012-01-24       Impact factor: 3.485

2.  Adapting problem-solving therapy for depressed older adults in methadone maintenance treatment.

Authors:  Daniel Rosen; Jennifer Q Morse; Charles F Reynolds
Journal:  J Subst Abuse Treat       Date:  2010-10-30

3.  The recognition and management of psychological reactions to stroke: a case discussion.

Authors:  Lyvia S Chriki; Szofia S Bullain; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

4.  Addressing both depression and pain in late life: the methodology of the ADAPT study.

Authors:  Jordan F Karp; Bruce L Rollman; Charles F Reynolds; Jennifer Q Morse; Frank Lotrich; Sati Mazumdar; Natalia Morone; Debra K Weiner
Journal:  Pain Med       Date:  2012-02-07       Impact factor: 3.750

5.  Problem solving therapy for subthreshold depression in home healthcare patients with cardiovascular disease.

Authors:  Zvi D Gellis; Martha L Bruce
Journal:  Am J Geriatr Psychiatry       Date:  2010-06       Impact factor: 4.105

6.  Improving function in age-related macular degeneration: design and methods of a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Robert W Massof; Benjamin E Leiby; William S Tasman
Journal:  Contemp Clin Trials       Date:  2010-10-23       Impact factor: 2.226

7.  Treatments for Depression in Older Persons with Dementia.

Authors:  Zvi D Gellis; Kimberly P McClive-Reed; Ellen Brown
Journal:  Ann Longterm Care       Date:  2009-02-02

8.  Psychotherapies for Late-Life Depression.

Authors:  Amanda R McGovern; Dimitris N Kiosses; Patrick J Raue; Victoria M Wilkins; George S Alexopoulos
Journal:  Psychiatr Ann       Date:  2014-03-01

9.  Depression in Homebound Older Adults: Recent Advances in Screening and Psychosocial Interventions.

Authors:  Namkee G Choi; Jo Anne Sirey; Martha L Bruce
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-12-07

10.  Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: a case study.

Authors:  R Scott Mackin; Patricia Areán; Alexandra Elite-Marcandonatou
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.